A customer’s account of Blinkit’s “instant doctor-call” service approving prescription-only medicines within minutes has triggered a wider debate on patient safety, medical ethics, and India’s escalating antimicrobial resistance crisis. The incident, which surfaced on X, has raised pressing concerns about whether critical healthcare decisions are being reduced to a convenience-driven e-commerce model.
A minute-long consultation that approved prescription drugs
X user Neha Moolchandani shared that she had added Candiderma Plus cream, Cheston Cold and Flu tablets, and the antibiotic Azicip to her Blinkit cart. Seconds later, she was connected to a “general physician” through the app. She reported that the consultation lasted barely a minute — during which the doctor approved the very medications she had already selected.
Senior doctors were quick to voice alarm, calling the model an “order-and-approve” system rather than a legitimate clinical consultation.
To verify the claim, India Today attempted a similar process. After adding Azithral 200 mg liquid — a prescription-only antibiotic used for bacterial infections — they were connected to a doctor identified only as “Dr Aiman”. When asked for basic verification such as full name, qualifications and workplace, the doctor refused to respond, ended the call abruptly, yet immediately issued a prescription.
Medical professionals say this lack of transparency from a doctor issuing prescription drugs is deeply troubling.
Experts call the practice unsafe, unethical and dangerous
Internal medicine specialist Dr Suranjit Chatterjee from Indraprastha Apollo Hospital criticised the practice as “completely wrong”, noting that real medical assessment requires time, examination, and often lab reports. Prescribing antibiotics without understanding a patient’s history, he warned, significantly increases the likelihood of incorrect treatment.
Hepatologist Dr Cyriac Abby Philips (widely known on X as “The Liver Doc”) was more blunt, describing the service as “dangerous” and “a paid promotion for a useless model”. He pointed out that the Blinkit doctor had diagnosed a fungal infection over a phone call and prescribed antibiotics for what appeared to be a viral cold — a combination he called “stupid and harmful”.
Dr Ajay Yadav added that teleconsultation has its place, but it cannot replace proper clinical evaluation. “Healthcare shouldn’t be reduced to an ‘order now’ model,” he said.
Doctors widely agree that hurried, incomplete consultations risk misdiagnosis, inappropriate antibiotic use, worsening of fungal infections, masking of underlying disease, and serious side-effects in vulnerable patients.
India’s worsening antibiotic resistance makes the issue critical
India already faces one of the world’s most severe antimicrobial resistance (AMR) crises. Unregulated antibiotic access is a major contributor — and medical experts fear that instant prescription services could greatly accelerate the problem.
Quick-commerce platforms risk:
- Normalising self-medication
- Making prescriptions a mere procedural formality
- Allowing anonymous or unverified doctors to clear restricted drugs
- Encouraging patients to skip critical medical examination
Studies indicate the scale of the problem:
- A Lancet study reports that more than 80% of Indian patients already carry resistant organisms even before undergoing diagnostic procedures for pancreatic or biliary diseases.
- A WHO report shows nearly one million cases annually in India involve bacteria resistant to carbapenem — a last-resort antibiotic.
- With few new antibiotics being developed globally, India faces a narrowing set of treatment options.
Doctors warn that misuse today could leave future generations without effective medicines.
Telemedicine rules prohibit such prescriptions
India’s Telemedicine Practice Guidelines, issued by the Ministry of Health, clearly prohibit prescribing antibiotics and antifungal medicines through teleconsultation, except in narrowly defined situations. Assessing bacterial or fungal infections, doctors emphasise, cannot be done responsibly over a rushed phone call with no physical examination.
The Blinkit case indicates a possible violation of these rules — and raises concerns about enforcement, oversight and platform accountability.
Should essential healthcare be this casual?
The incident exposes a deeper question: as digital platforms expand into healthcare, are critical safeguards being diluted in the race for convenience?
Prescription medicines are not like groceries or electronics; misuse has real and lasting consequences. The anonymous doctor who refused to identify themselves adds to concerns about transparency and professional accountability.
India’s push towards digital health seeks to expand access, but experts insist that accessibility cannot come at the cost of safety.
As antibiotic resistance grows, awareness must increase that prescription drugs cannot be treated as instant-delivery items — and that medical consultation must remain a careful, responsible process grounded in ethical practice.
Excerpt (125–150 characters)
Blinkit’s instant doctor-call service is facing criticism after prescription drugs were approved in minutes, raising concerns about safety, ethics and India’s antibiotic crisis.
Tags
blinkit, antibiotic resistance, telemedicine, digital health, medical ethics, india healthcare, amr crisis, newskarnataka